Free Trial

Cardiol Therapeutics (CRDL) News Today

Cardiol Therapeutics logo
C$2.54 -0.08 (-3.05%)
(As of 11/15/2024 ET)
Cardiol Therapeutics added to PRISM Emerging Biotech Index
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Shares Down 0.8% - Should You Sell?
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.8% - Should You Sell?
Cardiol Therapeutics Expands Trials for Heart Treatment
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Trading Down 19.7% - Here's What Happened
Cardiol Therapeutics (TSE:CRDL) Shares Down 19.7% - Time to Sell?
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Trading Up 1.1%
Cardiol Therapeutics (TSE:CRDL) Trading 1.1% Higher
Cardiol Therapeutics to present Phase II study results
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 0.8%
Cardiol Therapeutics (TSE:CRDL) Trading Up 0.8%
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 3.6%
Cardiol Therapeutics (TSE:CRDL) Shares Up 3.6%
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.6%
Cardiol Therapeutics (TSE:CRDL) Trading Up 1.6%
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Trading Down 0.7%
Cardiol Therapeutics (TSE:CRDL) Shares Down 0.7%
Cardiol Therapeutics Inc. stock logo
Insider Buying: Cardiol Therapeutics Inc. (TSE:CRDL) Director Purchases 50,000 Shares of Stock
Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) Director David Elsley bought 50,000 shares of the business's stock in a transaction that occurred on Monday, June 24th. The shares were bought at an average cost of C$2.77 per share, for a total transaction of C$138,490.00.
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Shares Up 11.7%
Cardiol Therapeutics (TSE:CRDL) Trading 11.7% Higher
Cardiol Therapeutics Inc. stock logo
Cardiol Therapeutics (TSE:CRDL) Trading 12.9% Higher
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 12.9%
CRDL:CA Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc Class A
CRDL.TO - Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. (CRDL.TO)
CRDL Cardiol Therapeutics Inc.
Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide

CRDL Media Mentions By Week

CRDL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRDL
News Sentiment

0.00

0.56

Average
Medical
News Sentiment

CRDL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRDL Articles
This Week

1

0

CRDL Articles
Average Week

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (TSE:CRDL) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners